Influenza, Human  >>  ASP7373  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ASP7373 / Shionogi
NCT00980447: Immunogenicity, Safety and Optimal Dose Finding Study of Recombinant Influenza H5N1 Vaccine in Healthy Young Adults

Completed
2
90
Japan
UMN-0501, UMN-05
UMN Pharma Inc.
Influenza, Virus Diseases
12/09
12/09
NCT01195038: Immunogenicity and Safety Study of a Booster Vaccination With a Recombinant H5N1 Influenza HA Vaccine in Primed Adults

Completed
2
87
Japan
Recombinant Influenza HA Vaccine (H5N1), UMN-0501
UMN Pharma Inc.
Influenza
01/11
01/11
NCT01450579: A Study to Evaluate the Immune Response to the ASP7373 and Its Safety in Healthy Adult Volunteers

Completed
2
180
Japan
ASP7373, Placebo
UMN Pharma Inc.
Healthy
12/11
12/11

Download Options